Clinigen Group Plc (CLIGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLIGF | TBPH | SPRY | ||
| Company | Clinigen Group Plc | Theravance Bio Ord | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 8.0157 | 19.62 | 8.99 | ||
| High | 8.0157 | 19.85 | 9.47 | ||
| Low | 8.0157 | 18.60 | 8.91 | ||
| Latest | 8.0157 | 18.90 | 9.23 | ||
| Change | -0.4043 | -0.76 | +0.23 | ||
| % Change | -4.80% | -3.87% | +2.56% | ||
| Volume | 42,300 | 107,252 | 214,164 | ||
| 20-Day Average Volume | N/A | 392,783 | 1,156,171 | ||
| Previous Close | 8.4200 | 19.66 | 9.00 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 19.50 | 9.75 | ||
| 20-Day Raw Stochastic | N/A | 17.67% | 33.49% | ||
| 20-Day Relative Strength | N/A | 47.18 | 44.69 | ||
| Weighted Alpha | N/A | +96.13 | -26.18 | ||
| Today's Opinion | N/A | 64% Buy | 88% Sell | ||
| Previous Opinion | N/A | 96% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -30.68% since 05/19/21 | -3.58% since 02/13/26 | +5.54% since 02/13/26 | ||
| Low | 8.0157 on 11/30/21 | 18.69 on 02/17/26 | 8.66 on 02/17/26 | ||
| High | 8.6500 on 08/25/21 | 20.40 on 02/17/26 | 9.64 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | -7.33% since 08/25/21 | -6.97% since 01/23/26 | -8.52% since 01/23/26 | ||
| Low | 8.0157 on 11/30/21 | 18.45 on 02/11/26 | 8.61 on 02/13/26 | ||
| High | 8.4200 on 11/15/21 | 20.60 on 02/09/26 | 10.79 on 01/27/26 | ||
| 3-Month | |||||
| %Chg | -2.72% since 07/19/21 | +1.89% since 11/21/25 | +23.06% since 11/21/25 | ||
| Low | 8.0157 on 11/30/21 | 17.25 on 12/17/25 | 7.56 on 11/24/25 | ||
| High | 8.6500 on 08/25/21 | 21.03 on 01/22/26 | 13.15 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | -30.68% since 05/19/21 | +35.37% since 08/22/25 | -30.81% since 08/22/25 | ||
| Low | 8.0157 on 11/30/21 | 13.47 on 09/11/25 | 6.66 on 11/21/25 | ||
| High | 8.6500 on 08/25/21 | 21.03 on 01/22/26 | 14.00 on 08/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 981,122 | 996,212 | 889,641 | ||
| Shares Outstanding, K | 122,400 | 50,672 | 98,849 | ||
| Annual Sales | 704,710,000 | 64,380,000 | 89,150,000 | ||
| Annual Net Income | 40,780,000 | -56,420,000 | 8,000,000 | ||
| Last Quarter Sales | N/A | 19,990,000 | 32,500,000 | ||
| Last Quarter Net Income | N/A | 3,620,000 | -51,150,000 | ||
| 60-Month Beta | 0.72 | 0.15 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.04 on 11/10/25 | -0.52 on 11/10/25 | ||
| Latest Earnings Date | 01/01/70 | 02/25/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.34 | 0.00 | ||